This report contains market size and forecasts of Devices for Inhaled Medications in global, including the following market information:
Global Devices for Inhaled Medications Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Devices for Inhaled Medications Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Devices for Inhaled Medications companies in 2020 (%)
The global Devices for Inhaled Medications market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Devices for Inhaled Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Devices for Inhaled Medications Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Devices for Inhaled Medications Market Segment Percentages, By Type, 2020 (%)
Dry Powder Inhalers
Metered-Dose Inhalers
Nebulizers
Soft Mist Inhaler
Global Devices for Inhaled Medications Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Devices for Inhaled Medications Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Household
Global Devices for Inhaled Medications Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Devices for Inhaled Medications Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Devices for Inhaled Medications revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Devices for Inhaled Medications revenues share in global market, 2020 (%)
Key companies Devices for Inhaled Medications sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Devices for Inhaled Medications sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Consort Medical
Inhalexper
Cambridge Consultants
Hovione
Catalent, Inc
VertMarkets, Inc
Qualicaps
3M
Aerovance
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
Civitas/Alkermes
GlaxoSmithKline
Hovione
Mannkind
Mantecorp
Meda
MicroDose Therapeutx
Novartis
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Devices for Inhaled Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Devices for Inhaled Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Devices for Inhaled Medications Overall Market Size
2.1 Global Devices for Inhaled Medications Market Size: 2021 VS 2027
2.2 Global Devices for Inhaled Medications Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Devices for Inhaled Medications Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Devices for Inhaled Medications Players in Global Market
3.2 Top Global Devices for Inhaled Medications Companies Ranked by Revenue
3.3 Global Devices for Inhaled Medications Revenue by Companies
3.4 Global Devices for Inhaled Medications Sales by Companies
3.5 Global Devices for Inhaled Medications Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Devices for Inhaled Medications Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Devices for Inhaled Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Devices for Inhaled Medications Players in Global Market
3.8.1 List of Global Tier 1 Devices for Inhaled Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Devices for Inhaled Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Devices for Inhaled Medications Market Size Markets, 2021 & 2027
4.1.2 Dry Powder Inhalers
4.1.3 Metered-Dose Inhalers
4.1.4 Nebulizers
4.1.5 Soft Mist Inhaler
4.2 By Type - Global Devices for Inhaled Medications Revenue & Forecasts
4.2.1 By Type - Global Devices for Inhaled Medications Revenue, 2016-2021
4.2.2 By Type - Global Devices for Inhaled Medications Revenue, 2022-2027
4.2.3 By Type - Global Devices for Inhaled Medications Revenue Market Share, 2016-2027
4.3 By Type - Global Devices for Inhaled Medications Sales & Forecasts
4.3.1 By Type - Global Devices for Inhaled Medications Sales, 2016-2021
4.3.2 By Type - Global Devices for Inhaled Medications Sales, 2022-2027
4.3.3 By Type - Global Devices for Inhaled Medications Sales Market Share, 2016-2027
4.4 By Type - Global Devices for Inhaled Medications Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Devices for Inhaled Medications Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Household
5.2 By Application - Global Devices for Inhaled Medications Revenue & Forecasts
5.2.1 By Application - Global Devices for Inhaled Medications Revenue, 2016-2021
5.2.2 By Application - Global Devices for Inhaled Medications Revenue, 2022-2027
5.2.3 By Application - Global Devices for Inhaled Medications Revenue Market Share, 2016-2027
5.3 By Application - Global Devices for Inhaled Medications Sales & Forecasts
5.3.1 By Application - Global Devices for Inhaled Medications Sales, 2016-2021
5.3.2 By Application - Global Devices for Inhaled Medications Sales, 2022-2027
5.3.3 By Application - Global Devices for Inhaled Medications Sales Market Share, 2016-2027
5.4 By Application - Global Devices for Inhaled Medications Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Devices for Inhaled Medications Market Size, 2021 & 2027
6.2 By Region - Global Devices for Inhaled Medications Revenue & Forecasts
6.2.1 By Region - Global Devices for Inhaled Medications Revenue, 2016-2021
6.2.2 By Region - Global Devices for Inhaled Medications Revenue, 2022-2027
6.2.3 By Region - Global Devices for Inhaled Medications Revenue Market Share, 2016-2027
6.3 By Region - Global Devices for Inhaled Medications Sales & Forecasts
6.3.1 By Region - Global Devices for Inhaled Medications Sales, 2016-2021
6.3.2 By Region - Global Devices for Inhaled Medications Sales, 2022-2027
6.3.3 By Region - Global Devices for Inhaled Medications Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Devices for Inhaled Medications Revenue, 2016-2027
6.4.2 By Country - North America Devices for Inhaled Medications Sales, 2016-2027
6.4.3 US Devices for Inhaled Medications Market Size, 2016-2027
6.4.4 Canada Devices for Inhaled Medications Market Size, 2016-2027
6.4.5 Mexico Devices for Inhaled Medications Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Devices for Inhaled Medications Revenue, 2016-2027
6.5.2 By Country - Europe Devices for Inhaled Medications Sales, 2016-2027
6.5.3 Germany Devices for Inhaled Medications Market Size, 2016-2027
6.5.4 France Devices for Inhaled Medications Market Size, 2016-2027
6.5.5 U.K. Devices for Inhaled Medications Market Size, 2016-2027
6.5.6 Italy Devices for Inhaled Medications Market Size, 2016-2027
6.5.7 Russia Devices for Inhaled Medications Market Size, 2016-2027
6.5.8 Nordic Countries Devices for Inhaled Medications Market Size, 2016-2027
6.5.9 Benelux Devices for Inhaled Medications Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Devices for Inhaled Medications Revenue, 2016-2027
6.6.2 By Region - Asia Devices for Inhaled Medications Sales, 2016-2027
6.6.3 China Devices for Inhaled Medications Market Size, 2016-2027
6.6.4 Japan Devices for Inhaled Medications Market Size, 2016-2027
6.6.5 South Korea Devices for Inhaled Medications Market Size, 2016-2027
6.6.6 Southeast Asia Devices for Inhaled Medications Market Size, 2016-2027
6.6.7 India Devices for Inhaled Medications Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Devices for Inhaled Medications Revenue, 2016-2027
6.7.2 By Country - South America Devices for Inhaled Medications Sales, 2016-2027
6.7.3 Brazil Devices for Inhaled Medications Market Size, 2016-2027
6.7.4 Argentina Devices for Inhaled Medications Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Devices for Inhaled Medications Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Devices for Inhaled Medications Sales, 2016-2027
6.8.3 Turkey Devices for Inhaled Medications Market Size, 2016-2027
6.8.4 Israel Devices for Inhaled Medications Market Size, 2016-2027
6.8.5 Saudi Arabia Devices for Inhaled Medications Market Size, 2016-2027
6.8.6 UAE Devices for Inhaled Medications Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Consort Medical
7.1.1 Consort Medical Corporate Summary
7.1.2 Consort Medical Business Overview
7.1.3 Consort Medical Devices for Inhaled Medications Major Product Offerings
7.1.4 Consort Medical Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.1.5 Consort Medical Key News
7.2 Inhalexper
7.2.1 Inhalexper Corporate Summary
7.2.2 Inhalexper Business Overview
7.2.3 Inhalexper Devices for Inhaled Medications Major Product Offerings
7.2.4 Inhalexper Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.2.5 Inhalexper Key News
7.3 Cambridge Consultants
7.3.1 Cambridge Consultants Corporate Summary
7.3.2 Cambridge Consultants Business Overview
7.3.3 Cambridge Consultants Devices for Inhaled Medications Major Product Offerings
7.3.4 Cambridge Consultants Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.3.5 Cambridge Consultants Key News
7.4 Hovione
7.4.1 Hovione Corporate Summary
7.4.2 Hovione Business Overview
7.4.3 Hovione Devices for Inhaled Medications Major Product Offerings
7.4.4 Hovione Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.4.5 Hovione Key News
7.5 Catalent, Inc
7.5.1 Catalent, Inc Corporate Summary
7.5.2 Catalent, Inc Business Overview
7.5.3 Catalent, Inc Devices for Inhaled Medications Major Product Offerings
7.5.4 Catalent, Inc Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.5.5 Catalent, Inc Key News
7.6 VertMarkets, Inc
7.6.1 VertMarkets, Inc Corporate Summary
7.6.2 VertMarkets, Inc Business Overview
7.6.3 VertMarkets, Inc Devices for Inhaled Medications Major Product Offerings
7.6.4 VertMarkets, Inc Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.6.5 VertMarkets, Inc Key News
7.7 Qualicaps
7.7.1 Qualicaps Corporate Summary
7.7.2 Qualicaps Business Overview
7.7.3 Qualicaps Devices for Inhaled Medications Major Product Offerings
7.4.4 Qualicaps Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.7.5 Qualicaps Key News
7.8 3M
7.8.1 3M Corporate Summary
7.8.2 3M Business Overview
7.8.3 3M Devices for Inhaled Medications Major Product Offerings
7.8.4 3M Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.8.5 3M Key News
7.9 Aerovance
7.9.1 Aerovance Corporate Summary
7.9.2 Aerovance Business Overview
7.9.3 Aerovance Devices for Inhaled Medications Major Product Offerings
7.9.4 Aerovance Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.9.5 Aerovance Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Devices for Inhaled Medications Major Product Offerings
7.10.4 AstraZeneca Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.10.5 AstraZeneca Key News
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Corporate Summary
7.11.2 Boehringer Ingelheim Devices for Inhaled Medications Business Overview
7.11.3 Boehringer Ingelheim Devices for Inhaled Medications Major Product Offerings
7.11.4 Boehringer Ingelheim Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.11.5 Boehringer Ingelheim Key News
7.12 Chiesi
7.12.1 Chiesi Corporate Summary
7.12.2 Chiesi Devices for Inhaled Medications Business Overview
7.12.3 Chiesi Devices for Inhaled Medications Major Product Offerings
7.12.4 Chiesi Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.12.5 Chiesi Key News
7.13 Cipla
7.13.1 Cipla Corporate Summary
7.13.2 Cipla Devices for Inhaled Medications Business Overview
7.13.3 Cipla Devices for Inhaled Medications Major Product Offerings
7.13.4 Cipla Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.13.5 Cipla Key News
7.14 Civitas/Alkermes
7.14.1 Civitas/Alkermes Corporate Summary
7.14.2 Civitas/Alkermes Business Overview
7.14.3 Civitas/Alkermes Devices for Inhaled Medications Major Product Offerings
7.14.4 Civitas/Alkermes Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.14.5 Civitas/Alkermes Key News
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Corporate Summary
7.15.2 GlaxoSmithKline Business Overview
7.15.3 GlaxoSmithKline Devices for Inhaled Medications Major Product Offerings
7.15.4 GlaxoSmithKline Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.15.5 GlaxoSmithKline Key News
7.16 Hovione
7.16.1 Hovione Corporate Summary
7.16.2 Hovione Business Overview
7.16.3 Hovione Devices for Inhaled Medications Major Product Offerings
7.16.4 Hovione Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.16.5 Hovione Key News
7.17 Mannkind
7.17.1 Mannkind Corporate Summary
7.17.2 Mannkind Business Overview
7.17.3 Mannkind Devices for Inhaled Medications Major Product Offerings
7.17.4 Mannkind Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.17.5 Mannkind Key News
7.18 Mantecorp
7.18.1 Mantecorp Corporate Summary
7.18.2 Mantecorp Business Overview
7.18.3 Mantecorp Devices for Inhaled Medications Major Product Offerings
7.18.4 Mantecorp Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.18.5 Mantecorp Key News
7.19 Meda
7.19.1 Meda Corporate Summary
7.19.2 Meda Business Overview
7.19.3 Meda Devices for Inhaled Medications Major Product Offerings
7.19.4 Meda Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.19.5 Meda Key News
7.20 MicroDose Therapeutx
7.20.1 MicroDose Therapeutx Corporate Summary
7.20.2 MicroDose Therapeutx Business Overview
7.20.3 MicroDose Therapeutx Devices for Inhaled Medications Major Product Offerings
7.20.4 MicroDose Therapeutx Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.20.5 MicroDose Therapeutx Key News
7.21 Novartis
7.21.1 Novartis Corporate Summary
7.21.2 Novartis Business Overview
7.21.3 Novartis Devices for Inhaled Medications Major Product Offerings
7.21.4 Novartis Devices for Inhaled Medications Sales and Revenue in Global (2016-2021)
7.21.5 Novartis Key News
8 Global Devices for Inhaled Medications Production Capacity, Analysis
8.1 Global Devices for Inhaled Medications Production Capacity, 2016-2027
8.2 Devices for Inhaled Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Devices for Inhaled Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Devices for Inhaled Medications Supply Chain Analysis
10.1 Devices for Inhaled Medications Industry Value Chain
10.2 Devices for Inhaled Medications Upstream Market
10.3 Devices for Inhaled Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Devices for Inhaled Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Devices for Inhaled Medications in Global Market
Table 2. Top Devices for Inhaled Medications Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Devices for Inhaled Medications Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Devices for Inhaled Medications Revenue Share by Companies, 2016-2021
Table 5. Global Devices for Inhaled Medications Sales by Companies, (K Units), 2016-2021
Table 6. Global Devices for Inhaled Medications Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Devices for Inhaled Medications Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Devices for Inhaled Medications Product Type
Table 9. List of Global Tier 1 Devices for Inhaled Medications Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Devices for Inhaled Medications Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Consort Medical
Inhalexper
Cambridge Consultants
Hovione
Catalent, Inc
VertMarkets, Inc
Qualicaps
3M
Aerovance
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
Civitas/Alkermes
GlaxoSmithKline
Hovione
Mannkind
Mantecorp
Meda
MicroDose Therapeutx
Novartis